S2996 revises New Jersey’s advanced practice nurse (APN) laws to remove or reduce several physician-collaboration requirements and expand APN authority to practice more independently. The bill’s core change is to create a pathway for certain APNs with more than 5,000 hours of licensed, active advanced practice experience in specified population focuses to practice without a joint protocol with a collaborating physician, so long as they are providing primary health care or behavioral health care and are not practicing in general obstetrics or elective cosmetic/aesthetic services. Those independently practicing APNs would also be able to order medications and devices, subject to education, insurance, notice, and reporting requirements.
The bill also updates the scope of APN authority in several related areas. It preserves and clarifies APNs’ ability to diagnose, monitor, manage, prescribe, and order tests and treatments, and it modifies rules for prescribing controlled dangerous substances, medical cannabis, substance use disorder services, and certain narcotic dispensing. It further provides that, where consistent with APN scope of practice, state laws or regulations requiring a physician’s signature, stamp, verification, affidavit, or endorsement may be satisfied by an APN. The bill directs the Board of Nursing and the Commissioner of Health to adopt implementing regulations quickly and includes a transition rule for APNs already practicing without a joint protocol under Executive Order No. 13 (2026).
In practical terms, the bill would amend multiple sections of Title 45 and related statutes governing nursing, controlled dangerous substances, and health care regulation. It would reduce the role of collaborating physicians in certain APN practices, while leaving the Board of Nursing and the Division of Consumer Affairs with authority over standards, discipline, and protocol-related regulation. The bill also imposes continuing education requirements, malpractice coverage requirements, and reporting obligations for independently practicing APNs, reflecting an effort to pair expanded autonomy with oversight.
The general sentiment reflected in the bill text and voting history is supportive of expanding APN practice authority, with the Legislature’s findings emphasizing access to care, physician shortages, underserved communities, and the lack of reported adverse incidents during pandemic-era waivers. The bill advanced through the Senate Judiciary Committee on an 8-2 vote and later passed both chambers, suggesting substantial bipartisan support for the overall policy direction.
The main point of contention is the degree of independence APNs should have and whether physician collaboration should remain mandatory. Supporters appear to view the bill as a response to access-to-care needs and a way to retain APNs in New Jersey, while opponents likely focused on patient safety, oversight, and the appropriate limits of independent prescribing and treatment authority. The bill’s exceptions, experience thresholds, and insurance/education requirements indicate a compromise between full autonomy and continued regulation.
The bill would substantially amend New Jersey’s nursing statutes, especially P.L.1991, c.377, by creating a statutory exemption from joint protocol requirements for qualified advanced practice nurses and by broadening APN authority to prescribe, order, and in some cases authorize cannabis and substance use disorder-related services without physician collaboration. It would also require conforming changes to rules governing controlled dangerous substances, Board of Nursing authority, and Health Department review standards, while authorizing emergency rulemaking to implement the new framework. Affected parties include advanced practice nurses, collaborating physicians, the Board of Nursing, the Division of Consumer Affairs, and patients seeking primary, behavioral, reproductive, and related care.
The overall sentiment appears favorable and reform-oriented. The bill’s findings frame APN independence as a solution to physician shortages, access disparities, and workforce retention, and the recorded votes show it moved through committee and both houses with clear majorities. The absence of committee transcript material limits a more granular read, but the legislative history suggests the proposal was broadly accepted as an access-to-care measure.
The central controversy is whether APNs should be allowed to practice without a collaborating physician and to prescribe or authorize medications independently after meeting experience and education thresholds. Supporters emphasize access, efficiency, and evidence from COVID-era waivers, while critics would likely worry about clinical oversight, prescribing safety, and the scope of independent practice. Additional tension may arise over the bill’s treatment of controlled substances, cannabis authorizations, and the extent to which physician-signature requirements are effectively converted to APN authority.